Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-03
2005-05-03
Shah, Mukund J. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S354000, C514S423000, C514S534000, C540S607000, C546S226000, C548S540000, C560S037000
Reexamination Certificate
active
06887866
ABSTRACT:
The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.
REFERENCES:
patent: 3086976 (1963-04-01), Hiltman et al.
patent: 3484527 (1969-12-01), Arnold et al.
patent: 3510559 (1970-05-01), Arnold et al.
patent: 3511877 (1970-05-01), Arnold et al.
patent: 4401830 (1983-08-01), Umumura et al.
patent: 4711902 (1987-12-01), Serno
patent: 4918092 (1990-04-01), Frenette et al.
patent: 5242944 (1993-09-01), Park et al.
patent: 1134 981 (1962-08-01), None
patent: 27 31 460 (1978-01-01), None
patent: 0 236 280 (1991-06-01), None
patent: 1032872 (1956-06-01), None
patent: 941694 (1963-11-01), None
patent: 961 265 (1964-06-01), None
patent: 1 571 395 (1980-07-01), None
patent: WO 9632135 (1996-10-01), None
“SUBLIMAZE ® 2ml injection, 10ml injection” 4 pages. South African Electronic Package Inserts. Published by Malahyde Information Systems. Publication date Apr. 19, 1984, Jan. 21, 1983.*
Strazzolini et al, “Nitrolysis of t-Butyl and 1-Adamantyl Esters” Tetrahedron Letters, vol. 39, pp. 9255-9258 (1998).*
Clarke, “The Eugends”, Intravenous Anaesthesia, Chapter 8, pp 162-192 (1974).
MacKenzie et al., “Formulation and evaluation of a propanidid hydroxypropryl-β-cyclodextrin solution for intravenous anesthesia”, Int. Journ. of Pharmaceutics. vol. 59, pp 191-196 (1997).
Swerdlow, “A Trial of Propanidid (FBA. 1420): A New Ultrashort-Acting Anaesthetic”, Brit J. Anaesth. vol. 37, pp 785-789 (1985).
Wynands et al., “A Clinical Study of Propanidid (FBA 1420)”, Can. Anaes. Soc. J., vol. 12, No. 6, pp 587-594 (1985).
Zipf et al., “Local and endoanesthetic side effects of the short-term narcotic, propanidid and some homologs. Effects of a solubilizer on the degree of activity”, Arzneim.-Forsch . . . vol. 17, No. 8, pp 1021-1026 (1967) (In German with English abstract).
Axt Sabine
Bolton Jennifer
Jenkins Thomas E.
Boone David E.
Hagenah Jeffrey A.
Saxon Robert P.
Shah Mukund J.
Theravance Inc.
LandOfFree
Short-acting sedative hypnotic agents for anesthesia and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Short-acting sedative hypnotic agents for anesthesia and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Short-acting sedative hypnotic agents for anesthesia and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3426145